Abbott Laboratories stock fell Thursday after the medical-products maker reporting disappointing results, hit by a slump in the division that makes baby formula and nutrition shakes.
Fourth-quarter sales in the nutrition business, which includes Similac baby formula and Ensure drinks, dropped 8.9%
Fourth-quarter sales in the nutrition business, which includes Similac baby formula and Ensure drinks, dropped 8.9%
